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Prevention and early intervention 
of coexisting mental health and 
substance use issues
Netzach Goren, Research Fellow and Jane Mallick, Director, 
Centre for Youth Drug Studies, Australian Drug Foundation
Depressive symptoms are expected to be the second leading cause of disease burden in the 
Western world by 2020 (Lopez & Murray 1998). Current research shows that approximately 
25 per cent of young people who present with a psychological disorder also present with a 
comorbid disorder, the most prevalent relating to substance misuse (Teesson, Hall, Lynskey & 
Degenhardt 2000). The longer term economic implications of failure to address mental health 
and substance use disorders are potentially enormous. Already mental health expenditure is 
around $2 billion per year (Commonwealth of Australia 1996).
Individuals with comorbid disorders use more 
public services and are more dependent on 
welfare benefits than individuals with a single 
disorder (Australian Institute of Health and Welfare 
2005; Teesson & Proudfoot 2003). Individuals 
with comorbid disorders are also more likely to 
develop a wide range of problems such as legal, 
relationship, family and financial difficulties 
(Osher & Kofoed 1989; Reis 1992). The Council 
of Australia Governments (COAG) has recently 
renewed its commitment to prevention, early 
detection and intervention in the areas of mental 
health and substance abuse, including illicit 
drugs (such as cannabis and amphetamine-type 
substances) and alcohol (Council of Australian 
Governments’ Meeting 2006).
The relationship between mental health and  
alcohol and other drug issues is well-recognised but 
a corresponding need for synergy and partnership 
between the drug and alcohol and mental health 
sectors is lacking. The purpose of this paper is 
two-fold:
Provide an overview of recent scientific evidence  ◗
about comorbidity between psychological 
disorders (e.g. depression, anxiety and 
schizophrenia) and specific types of substances 
(e.g. cannabis, psychostimulants and alcohol).
Present key examples of prevention and early  ◗
intervention initiatives showing particular promise.
Comorbidity refers to “any distinct additional clinical 
entity that has existed or that may occur during 
the clinical course of a patient who has the index 
disease under study” (Feinstein 1970). The term can 
be applied to the co-occurrence of two or more 
psychological and/or physical health conditions. It 
is estimated that the lifetime prevalence of mental 
health disorder (excluding substance use disorders) 
is around 22–23 per cent and that around 29 per 
cent of those with a mental health disorder have a 
coexisting substance use disorder. (Andrews 1997; 
Bijl, Ravelli & van Zessen 1998; Fichter et al. 1996; 
Regier et al. 1990; Wang et al. 1992).
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Causal relationships between psychological 
and substance use disorders have been broadly 
categorised into three main types: direct causation, 
indirect causation, and common aetiology.
Direct causation is where there is a clear 
relationship between substance misuse and mental 
disorder, or mental disorder and substance misuse.  
An example of direct causation might be self 
medication of depressive symptomatology (Khantzian 
1985). Another example might be the effect of some 
drugs (e.g. cannabis and amphetamines) may trigger 
psychotic symptoms (e.g. cannabis or amphetamine 
psychoses) and other mental health problems, 
particularly for at-risk individuals (Arseneault, Cannon 
& Poulton 2002; Hall & Degenhardt 2000; Zammit, 
Allebeck & Andreasson 2002).
Indirect causation is where one disorder has an 
effect upon another factor that, in turn, increases 
the likelihood of developing the second disorder 
(Degenhardt, Hall and Lynskey 2003). For instance, there 
is some evidence to suggest that drug use can lead to 
financial strain (Orford 1998); this in turn may increase 
the likelihood of other problems, such as depression.
Common aetiology causation is where substance 
use and mental health disorders are brought about  
by one or more common factors. These can be 
biological (e.g. genetic factors), environmental  
and/or social risk factors, such as social disadvantages, 
family separation and low socio-economic levels  
(Caron & Rutter 1991; Eysenck & Eysenck 1991;  
Smit, Bolier & Cuijpers 2004).
Cannabis and mental health
Prevalence
Cannabis is the most widely used illicit substance 
in the general population. According to the 2005 
National Household Survey, 11.3 per cent of 
Australians aged 14 years and older reported using 
cannabis during the previous 12 months (Australian 
Institute of Health and Welfare 2005).
Evidence of comorbidity
The relationship between cannabis and mental health 
has been on the agenda of the research community 
for many years, with most studies targeting the 
relationship between cannabis and psychosis/
schizophrenia (Arseneault, Cannon & Poulton 2002; 
Degenhardt & Hall 2001; Fergusson, Horwood & 
Swain-Campbell 2003; van Os, Bak & Bijl 2002) 
and, to a lesser extent, depression and anxiety 
(Arseneault, Cannon & Poulton 2002; Goodwin, 
Fergusson & Horwood 2004). However, there is 
evidence of comorbidity with mood disorders. Those 
diagnosed with a mood disorder are approximately 
3–6 times more likely to have cannabis-related 
disorders (Andrews 1997; Grant & Harford 1995). The 
prevalence of anxiety disorders is 5.7 per cent within 
the general population compared with 17 per cent 
among those presenting with a cannabis dependence 
disorder (Degenhardt, Hall & Lynskey 2001).
Evidence of causation
In a prospective longitudinal study of adolescent 
health and wellbeing conducted in Victoria, frequent 
cannabis use during adolescence was found to be a 
strong predictor of depression and anxiety in young 
adulthood, particularly among daily users (Patton et 
al. 2002). In a 21 year longitudinal study conducted 
by Fergusson, Horwood & Swain-Campbell (2003) 
cannabis dependence at age 18 was found to be 
a strong predictor of psychotic symptoms in users 
at age 21. Chronic cannabis exposure has been 
associated with more persistent forms of psychiatric 
disorder, particularly schizophrenia (Degenhardt & 
Hall 2006; Hall & Degenhardt 2000).
Smit, Bolier & Cuijpers (2004) conducted a review of 
five population-based, longitudinal studies on the 
relationship between cannabis use and schizophrenia. 
They concluded that cannabis use may trigger 
schizophrenia in vulnerable groups (e.g. people with a 
family history of schizophrenia); however, antecedent 
use of cannabis may also be a risk factor for a later 
onset of schizophrenia in people with no previous family 
history of this illness (Smit, Bolier & Cuijpers 2004).
Alcohol and mental health
Prevalence
Alcohol is the most widely used psychoactive 
substance within the general Australian population, 
with 84 per cent of the population aged 14 years and 
over reporting having drunk alcohol at least once in 
the past 12 months and 9 per cent of Australians, 
having consumed it on a daily basis (Australian 
Institute of Health and Welfare 2005).
3Issues Paper  |  No. 3  |  November 2007
Evidence of comorbidity
Research with psychiatric populations has identified the 
coexistence of alcohol-related disorders with depression 
and anxiety (Hesselbrock 1991; Kovacs, Goldstein & 
Gatsonis 1993; Raimo & Schuckit 1998). However, 
research from psychiatric populations is limited in terms 
of ascertaining comorbidity of alcohol and mental health 
disorders within the general population.
Findings from the American National Comorbidity 
Study carried out in 1997 revealed that the probability 
of a major depressive disorder among respondents 
with a diagnosis of alcohol dependence was 28 per 
cent (Kessler et al. 1997). Within the alcohol 
dependence group, 37 per cent presented with at 
least one type of anxiety disorder (Kessler et al. 1997).
Similar findings have emerged from Australian 
studies. When controlling for other sociodemographic 
variables (gender, age, employment) one-third 
of participants with an alcohol-related disorder 
(dependence or abuse) also had at least one mental 
health disorder: anxiety, depression or other drug use 
disorder (Burns & Teesson 2002). In addition, 19 per 
cent of respondents with a mental health disorder 
also had an alcohol use disorder, either abuse or 
dependence. Clearly, mental health disorders are 
more common among people with alcohol-related 
disorders than among the general population.
Evidence of causation
Results from the Epidemiologic Catchment Area study 
carried out in the United States of America indicated 
that among those who had abused alcohol, 12.3 per 
cent also met the criteria for a mood disorder during 
the previous year (Regier et al. 1990). In a birth 
cohort study carried out by Fergusson, Lynskey & 
Horwood (1994) in New Zealand, relationships were 
found between alcohol abuse, depression, anxiety 
and suicidal behaviour.
Psychostimulants and mental health
Prevalence
Eleven per cent of students surveyed as part of the 
Australian secondary school students’ use of alcohol 
in 1999 survey, reported the use of amphetamine-
like stimulants (White 2001). There was a 2 per cent 
increase in use compared with the results in 1996 
(White 2001). Ecstasy is the third most commonly 
used illicit drug in Australia (Degenhardt, Copeland 
& Dillon 2005), with approximately 1.2 million 
Australians aged 14 and over having used the drug 
at least once during their life (Australian Institute of 
Health and Welfare 2005).
Evidence of comorbidity
Both, amphetamine and methamphetamine have 
been associated with psychological symptoms such 
as depression, anxiety and psychotic behaviour 
(Baker, Lee & Jenner 2004). A range of psychological 
problems have been reported among chronic 
injecting amphetamine users, including mood swings 
(80 per cent), anxiety (72 per cent) and depression 
(71 per cent; Hall & Hando 1993). The emergence 
of “ice”, a form of methamphetamine also known 
as “crystal meth”, has also been linked to psychotic 
symptoms such as paranoia, hallucinations, 
anxiety and depression among Australians who 
use methamphetamines (Topp et al. 2002).
Evidence of causation
Evidence suggests that different types of 
psychostimulants can induce acute short-term  
states of panic, depression or psychosis. For 
instance, Montoya et al. (2002) found that 
people who use ecstasy tend to report a wide 
range of psychological side effects, including 
anxiety, depression, depersonalisation, confusion, 
hallucinations, panic attacks and paranoia. The most 
commonly reported symptoms are panic attacks/
anxiety and toxic psychoses. Panic attacks tend 
to occur within the first hour of ecstasy ingestion 
(Williamson et al. 1997).
Soar, Turner & Parrott (2001) carried out a literature 
review of previously published psychiatric case 
studies (1991–2001) where ecstasy was used. They 
found that only 24 per cent of users who reported 
psychological difficulties had a history of psychiatric 
problems whereby 34 per cent indicated a family 
history of mental illness. This suggests that ecstasy 
use could be a factor in the manifestation of some 
psychiatric symptoms. More recently Dutch researchers 
carried out a 14 year longitudinal study on a sample 
of 1580 individuals, from childhood into adulthood 
(Huizink et al. 2006) in order to ascertain whether the 
use of ecstasy is preceded by psychological problems 
during childhood. Those with symptoms of anxiety or 
depression in childhood were more likely to use the 
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drug later on in life. These findings are also consistent 
with a previous study which found that individuals with 
anxiety disorders (e.g. phobias) at baseline were more 
likely to use ecstasy in the future (at 4 year follow-up; 
Lieb et al. 2002).
Vincent et al. (1998) found that approximately 
one-third of the people in their sample who used 
amphetamines reported symptoms of anxiety and 
depression before they began to use the drug 
with 25 per cent reporting symptoms of anxiety, 
depression and panic attack after they started to 
use the drug. They found a relationship between an 
increased severity of dependence and the number 
of psychological symptoms experienced by people 
who use amphetamines (Vincent, Schoobridge, 
Ask, Allsop & Ali 1998). However, as this was not 
a longitudinal design, these results should be 
interpreted with caution. 
Prevention interventions
The Mental Health Intervention Spectrum is a widely 
used model comprising three main components: 
prevention, treatment and maintenance (Figure 1; 
Mrazek and Haggerty 1994). Prevention interventions 
aim to reduce the risk of the initial onset of a mental 
disorder whereas treatment interventions aim to 
stop the progression of a condition or reduce its 
severity. Maintenance interventions focus on relapse 
prevention and the provision of rehabilitation 
solutions to patients. In practice, the line between 
prevention and treatment is vague as both 
components aim for early intervention with the dual 
purpose of prevention and minimising the severity 
of the condition. Another form of intervention that 
is applicable to the entire intervention spectrum is 
mental health promotion, which aims to improve 
the mental health and wellbeing of both the general 
population and individuals.
Traditionally, the focus of Australian mental health 
services has been mostly on treatment of severely 
mentally ill people (Raphael 2000a). However, 
compared with patients who present with either 
mental health or substance use disorders, the 
success rates for treatment of individuals with two 
or more psychological disorders are lower and 
these individuals are more likely to relapse after 
improvement in their condition (Hall 1996; Jaffe & 
Ciraulo 1986). There is an important need for an 
integrated approach that addresses the complexity of 
comorbidity (Dadds et al. 1997; Degenhardt, Hall & 
Lynskey 2003; Kosky & Hardy 1992).
Figure 1: The mental health intervention spectrum (Mrazek & Haggerty 1994).
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Universal, selective and indicated 
intervention strategies
Universal interventions are designed for the 
general population or a whole population group that 
has not been identified on the basis of individual 
risk. A large body of research supports universal 
interventions that aim to prevent alcohol and other 
drug-related problems (eg Raphael 2000a) and there 
is also some evidence for the effectiveness of universal 
interventions to prevent psychological disorders 
(Kolbe 1997; Raphael 2000b). 
Selective interventions target individuals or  
at-risk groups. Characteristics such as age, gender, 
occupation or exposure to risk factors (e.g. single 
parenting) can be indicators for these groups 
(Commonwealth of Australia 1996).
Indicated interventions also known as early 
interventions, target individuals who are already 
presenting some early signs of psychological disorders 
or have genetic markers (e.g. family history) related 
to such conditions. At this early stage, however, 
such people do not yet meet the criteria of a mental 
disorder (Commonwealth of Australia 1996).
Because mood and substance use disorders typically 
occur in adolescence and young adulthood (Andrews 
& Wilkinson 2002), most prevention approaches 
focus on the child and adolescent years before early 
symptoms of disorder present (Andrews & Wilkinson 
2002). Harm minimisation is a central component of 
prevention strategies in Australia and involves a focus 
on reducing risk factors and enhancing protective 
factors known to be associated with a particular 
disorder (Commonwealth Department of Health and 
Aged Care 2000; Commonwealth of Australia 1996; 
Dadds et al. 1997; Durlak 1995; Loxley et al. 2004).
Risk factors increase the likelihood that a disorder will 
occur. Protective factors are characteristics, variables 
and/or conditions present in individuals or groups 
that enhance resilience, increase resistance to risk 
and fortify against the development of a disorder or 
adverse outcome (Commonwealth of Australia 1996; 
Loxley et al. 2004). Prevention researchers use risk 
status to identify populations for intervention. They 
then try to reduce the influence of risk factors and 
to enhance the effect of protective factors. Thus, an 
indication of a successful intervention would be: the 
degree of risk decreases, protective factors increase, 
the likelihood of onset of the potential problem also 
decreases (Resnick et al. 1997).
Interestingly, examination of multiple fields of 
prevention (e.g. mental health, drug use, physical 
health) suggests that there are a common set of risk 
and protective factors that influence children and 
families (Durlak & Wells 1997a). Table 1 lists the 
common risk factors that influence the development 
of mental and substance use disorders. Table 2 lists 
the common protective factors.
There are striking commonalities in risk and 
protective factor profiles for mental health and 
substance use outcomes. It follows that prevention 
of both outcomes should be able to be addressed 
by similar strategies. This is also reflected by 
the growing international support for a more 
comprehensive approach to the prevention of risk 
and for the promotion of positive mental health 
and youth development (Burton & Marshall 2005; 
Commonwealth Department of Health and Aged 
Care 2000; Commonwealth of Australia 1996; Jorm 
& Griffiths 2006; Loxley et al. 2004; Thompson 
2005). There is some evidence that the risk focussed 
approach has reduced risk of drug use and enhanced 
school performance (Durlak & Wells 1997a,b).
Examples of successful prevention 
intervention strategies
Communities that Care—a universal 
community based intervention
Communities That Care (CTC) is a mental health 
promotion and prevention program based on 
the risk and protective paradigm. The program 
aims to prevent health and social problems such 
as crime and other antisocial behaviour by young 
people, drug and alcohol misuse and issues relating 
to school failure. The CTC assists communities 
in tailoring and implementing evidence-based 
strategies that are specifically relevant to their needs 
(World Health Organization 2004). The original 
CTC program has been implemented successfully 
in communities in the USA and is currently being 
adopted in Australia by the Centre for Adolescent 
Health (Hawkins, Catalano & Arthur 2002).
Figure 1: The mental health intervention spectrum (Mrazek & Haggerty 1994).
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Table 1: Risk factors potentially influencing the development of mental health and substance  
use disorders
Individual Family School Community Life events 
Difficult 
temperament 
Poverty Early school failure Community 
disadvantages and 
disorganisation 
Unemployment
Aggression Family breakdown Peer relationship 
(e.g. social isolation 
or relationship 
with peers who 
are involved in 
drug use) 
Neighbourhood 
violence  
and crime 
Trauma  
(e.g. physical, 
mental or 
sexual abuse)
Parent and family 
substance use 
behaviours 
War or natural 
disaster 
Isolation 
Neglected in 
childhood 
Family  
breakdown
Commonwealth of Australia 1996; Dadds et al. 2003; Durlak 1998; Durlak & Wells 1997a; Loxley et al. 2004
Table 2: Protective factors potentially influencing the development of mental health and substance 
use disorders
Individual Family School Community Life events 
Easy temperament Low parental 
conflict 
Opportunities 
for positive social 
involvement—sense 
of belonging 
Religious 
involvement 
Economic security 
Social and 
emotional 
competence 
Family harmony Opportunities 
for some success 
and rewards for 
achievements 
A well-managed 
environment 
Involvement with 
significant other 
adult person 
Family norms Opportunities 
for positive social 
involvement—sense 
of belonging
Commonwealth of Australia 1996; Dadds et al. 2003; Durlak 1998; Durlak & Wells 1997a; Loxley et al. 2004
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The Gatehouse Project—a universal 
school based intervention
This project was developed by the Centre for 
Adolescent Health in Victoria. It integrates 
professional teams with backgrounds in education, 
psychology, psychiatry and health promotion 
(Glover et al.1998). The primary aim of the project 
is to promote adolescents’ mental health by 
creating an environment that increases feelings 
of wellbeing, security, a sense of belonging and 
positive feelings (Patton et al. 2000). The project 
provides schools with professional development 
tools and models to assist them to enhance 
their students’ connectedness to the school, and 
to improve students’ coping skills for everyday 
challenging situations (Cahill, Murphy & Hughes 
2005). An evaluation of the project found 
improvements in health indicators, including a 
significant reduction in drug and alcohol intake. 
Interestingly, the Gatehouse Project demonstrated 
that a program that aimed to improve mental 
health and wellbeing had an impact on drug and 
alcohol intake (Patton et al. 2000).
Seasons for Growth—a 
selective intervention
Seasons for Growth is a national grief and loss 
program that provides young people with a better 
understanding and management of family grief 
(e.g. death, divorce, separation and other forms of 
serious loss). The program is based on extensively 
researched and evidenced psychological and 
health promotion theories (e.g. narrative theory, 
cognitive behaviour theory and resilience-building 
interventions). The primary goal of the project is to 
promote mental health, psychological competence 
and early intervention for “at risk” young people 
(Cahill, Murphy & Hughes 2005). It is a short-term 
peer support program that focuses on building 
individual and group resilience (Dowling 2003). Pre- 
and post test evaluation shows that participation 
in the program leads to improved use of positive 
coping strategies and reduction in negative coping 
techniques (Frydenburg & Muller 2005). Furthermore, 
Frydenberg and Muller (2005) found that the 
program provided children with the right coping skills 
to express their feelings on matters they had been 
previously unable to articulate.
Other promising 
prevention initiatives
A universal mental health literacy program
It has been argued that many Australians have minimal 
awareness of mental health issues (Jorm et al. 1997). 
This lack of knowledge, along with social stigma and 
negative attitudes towards mental health disorders all 
contribute to the delay in seeking help (Jorm & Griffiths 
2006). Therefore, by increasing mental health literacy 
within the general population, the public can more 
effectively respond to mental health problems in the 
community (Jorm et al. 2004).
A universal self-help program
Jorm and Griffiths (2006) argue that there are many 
forms of self-help interventions that are suitable for 
population-wide dissemination; they are scientifically 
proven to be effective and they contain minimal risks 
for users (e.g. physical activity, cognitive behavioural 
therapy and relaxation techniques). In addition, web-
based dissemination of informal self-help strategies 
is cost effective and found to be effective in the 
reduction of the symptoms of depression and anxiety 
(Jorm & Griffiths 2006). It is also evident that the 
community needs to be informed about ineffective 
self-help strategies, including the use of alcohol to 
relax (Jorm et al. 1997).
A national peak body for depression 
and related disorders: beyondblue
Beyondblue is a national, independent, not-for-profit 
organisation working to address issues associated 
with depression, anxiety and related substance misuse 
disorders in Australia. It is a bipartisan initiative of 
the Australian, state and territory governments with 
a key goal of raising community awareness about 
depression and reducing stigma associated with the 
illness. Beyondblue’s five priorities are:
Increasing community awareness of depression,  ◗
anxiety and related substance misuse disorders 
and addressing associated stigma.
Providing people living with depression and their  ◗
carers with information on the illness and effective 
treatment options and promoting their needs and 
experiences with policy makers and healthcare 
service providers.
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Developing depression prevention and early  ◗
intervention programs.
Improving training and support for general  ◗
practitioners and other healthcare professionals 
on depression.
Initiating and supporting depression-related  ◗
research.
While beyondblue’s main focus is depression and 
anxiety, they too recognise comorbidity, in particularly 
alcohol and depression, and as such, they played  
a key role in the development of The National youth 
depression & alcohol review and action plan  
(Hodges et al. 2005).
Beyondblue has attempted to improve depression 
literacy through widespread social marketing 
strategies. In an evaluation of their public awareness 
campaign, Pirkis (2004) found that almost 75 per 
cent of the sample studied agreed that beyondblue 
had increased the public’s awareness of depression 
and reduced the degree of stigma associated with 
the illness. 
Screening for the early 
intervention of comorbidity
During the past decade several standard assessment 
instruments have been developed for the purposes 
of identifying comorbidity for early intervention 
(Drug Strategies 2002). Examples of such screening 
instruments include:
Substance Abuse Subtle Screening Inventory  ◗
(Miller 1999)
Problem Oriented Screening Instrument for  ◗
Teenagers (Rahdert 1991)
Personal Experience Screening Questionnaire  ◗
(Winters 1991).
Each explores a range of problematic issues relating 
to mental health and substance use and are easy to 
use measures for evaluation (Drug Strategies 2002).
New directions in prevention 
of comorbidity in Australia
While early intervention programs that solely target 
mental health issues are currently available in 
Australia, less attention has been given to programs 
that address coexisting problems of mental illness and 
drug use. Furthermore, the majority of mental health 
early intervention programs do not have an evaluation 
component and others have only limited evaluation 
(Davis et al. 2000).
There are however a number of new initiatives. For 
example, ORYGEN Research Centre, in conjunction 
with Youth Substance Abuse Service (YSAS), Drug 
and Alcohol Services Western Health (DASWest) 
and Youth Outreach Team in Victoria have recently 
commenced a research project that aims to develop 
an evidence-based assessment and treatment service 
for young people with comorbid disorders. In 
terms of early identification, the research team are 
attempting to develop screening tools that alcohol 
and other drug services can use to identify young 
people who are experiencing both drug use and 
mental illness. 
As part of the project, drug and alcohol workers 
will be trained and supervised in aspects of mental 
health practice. The research is part of the Substance 
Use Research Recovery Focussed (SURRF) program 
that was established in order to investigate the 
aetiology of, and potential treatment for, substance 
use disorders among young people with or without 
mental illness.
In another research project undertaken by Turning 
Point Alcohol and Drug Centre, a mental health 
screening tool and comorbidity intervention has 
been developed and trialled within alcohol and 
other drug treatment services. The aim of the 
screening tool, known as PsyCheck, is to increase 
the detection of mental health problems among 
drug and alcohol patients.
Headspace is Australia’s recently formed National 
Youth Mental Health Foundation. It was established 
out of the recognition of the need to respond more 
effectively to young people with mental health and 
alcohol and other drug issues. A major initiative of 
headspace is the Youth Services Development Fund 
which aims to create new models for delivering 
mental health services to young people and to 
build the capacity of local communities to identify 
and provide early and effective responses to young 
people with mental health and alcohol and other 
drug issues. Other priorities and initiatives of 
headspace include:
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collecting and building on the best available  ◗
evidence-based practice in young people’s  
mental health through the Centre of Excellence
encouraging early help seeking by young   ◗
people with mental health and substance use 
issues through local and national community 
awareness activities
assisting a range of service providers who   ◗
work with young people to build their skills 
through education and training resources  
and initiatives.
The recent commitment to headspace, National 
Youth Mental Health Foundation, and the range 
of early intervention initiatives being funded, will 
see this area expand in both service and practice 
but also, with the research of these initiatives, the 
evidence base will be developed.
Conclusions
Comorbidity has been associated with poor prognosis 
and heavy costs for individuals, families and society, 
and there is an increasing need to provide efficient 
and effective prevention, early intervention and 
treatment programs. In Australia the recent COAG 
agenda highlights the political will and commitment 
to this. There is a clear need for further research 
into comorbidity, including rigorous evaluations 
of comorbidity interventions. Research is needed 
not only to further understand the comorbid 
presentation of alcohol and other drug and mental 
health problems, but also to determine the most 
effective prevention, early intervention and treatment 
approaches. The common theoretical underpinning 
of the risk and protective paradigm offers one model 
for prevention programs within the mental health 
and drug and alcohol sectors. Rather than programs 
focusing on alcohol or cannabis, or depression or 
suicide, there clearly needs to be greater coordination 
between sectors. In addition, while mental health 
awareness and literacy, self-help tools and screening 
tools for professionals are identified as early 
intervention strategies there is a need to evaluate 
these programs to ascertain the most effective 
approaches and the impact they have on people’s 
mental health and drug and alcohol use.
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Button TMM, Rhee SH, Hewitt JK, Young SE, Corley 
RP & Stallings MC 2007 “The role of conduct disorder 
in explaining the comorbidity between alcohol and illicit 
drug dependence in adolescence”, Drug and Alcohol 
Dependence, 87:1, 46–53 
It is concluded that conduct disorder in adolescents 
explains, in part, the co-occurrence of alcohol and 
illicit drug dependence. Specifically, the genetic 
contribution to their covariation is explained partially 
by the genetic contribution in common with conduct 
disorder. (Elsevier)
Feinberg ME, Ridenour TA & Greenberg MT 
2007 “Aggregating indices of risk and protection for 
adolescent behavior problems. The Communities That 
Care Youth Survey”, Journal of Adolescent Health,  
40, 506–13 
This study aimed to facilitate research on adolescent 
risk and protection regarding behaviour problems, 
and to facilitate community decision-making 
regarding resource allocation for intervention 
programs, by creating a reduced set of coherent 
aggregate indices of adolescent risk and protection. 
(Elsevier)
DrugInfo Clearinghouse no. vf FEINBERG 07
Tracy K & Babuscio T 2007 “Contingency management to 
reduce substance use in individuals who are homeless with 
co-occurring psychiatric disorders”, The American Journal 
of Drug and Alcohol Abuse, 33:2, 253–8
Overall retention in the trial was high; participants 
assigned to contingency management reduced 
their cocaine and alcohol use more than those 
in assessment-only. This pilot trial suggests that 
application of low-cost contingency management 
procedures is feasible within this novel setting and 
may decrease substance use. (Taylor and Francis)
Anderson KG & Ramo DE 2006 “Life stress coping 
and comorbid youth. An examination of the stress 
vulnerability model for substance relapse”, Journal of 
Psychoactive Drugs, 38:3, 255–62 
The impact of life stress on alcohol and other drug 
use is influenced by psychosocial risk and protective 
factors. The article discusses how coping skills can 
impact on relapse and negative events.
Crow I, France A & Hacking S 2006 “Evaluation 
of three Communities That Care projects in the UK”, 
Security Journal, 19, 45–57 
The research raises important issues about the 
implementation of community-based programs 
based on a risk factor model, and the lessons to be 
learned from initiatives that focus on preventing 
the development of problem behaviour by early 
intervention with children. (Palgrave Macmillan)
DrugInfo Clearinghouse no. vf CROW 06
Hallfors D, Cho H, Brodish PH & Flewelling R 2006 
“Identifying high school students at risk for substance 
use and other behavioural problems: implications for 
prevention”, Substance use and Misuse, 41:1, 1–15 
Attendance and grade point average (GPA) data are 
universally maintained in school records and can 
potentially aid in identifying students with concealed 
behavioural problems, such as substance use. 
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Researchers evaluated attendance (truancy) and GPA 
as a means to identify high school students at risk for 
substance use, suicide behaviours, and delinquency 
in 10 high schools in San Antonio, Texas, and San 
Francisco, California. (Taylor & Francis)
Huizink AC, Ferdinand RF, van der Ende J &Verhulst 
FC 2006 “Symptoms of anxiety and depression in 
childhood and use of MDMA: prospective, population 
based study”, BMJ, 332, 825–8
This study investigated whether using ecstasy is 
preceded by symptoms of behavioural and emotional 
problems in childhood and early adolescence. It was 
concluded that individuals with symptoms of anxiety 
and depression in childhood would be more likely to 
use the drug. 
http://www.bmj.com/cgi/rapidpdf/
bmj.38743.539398.3Av1
DrugInfo Clearinghouse no. HUIZINK 06
Patton GC, Bond L, Carlin JB & Thomas L 2006 
“Promoting social inclusion in schools. A group-
randomized trial of effects on student health and  
risk behavior and well being”, American Journal of Public 
Health, 26:9, 1582–6 
The Gatehouse Project was designed as a structural 
process to promote a sense of social inclusion and 
connection in secondary schools. The interventions 
occurred during a two year period beginning in 1997. 
The study provides support for prevention strategies 
in schools that move beyond health education to 
promoting positive social environments. (AJPH)
DrugInfo Clearinghouse no. vf PATTON 06
Roberts AR & Corcoran K 2005 “Adolescents growing 
up in stressful environments, dual diagnosis, and sources 
of success”, Brief Treatment and Crisis Intervention, 5, 
1–8 
This article investigates social and psychological 
challenges to young people in today’s society. The 
authors believe that “dual diagnosis” is the typical 
experience of at-risk youths once they are diagnosed 
at mental health centres or juvenile justice reception 
and diagnostic centres, and conclude that evidence-
based assessment, intervention, prevention, and 
health promotion will prevent misdirected diagnosis 
and treatment. 
http://brief-treatment.oxfordjournals.org/cgi/
reprint/5/1/1 
vf ROBERTS 05
Roe S & Becker J 2005 “Drug prevention with 
vulnerable young people. A review”, Drugs Education 
Prevention & Policy 12:2 85–99
The aim of this study was to carry out a 
comprehensive and systematic review of the literature 
on drug-use prevention with vulnerable young 
people. Across different settings the 11–13 year age 
range appeared to be a crucial period for intervention 
with vulnerable young people. All of the sixteen 
studies included in the review were from North 
America. (Informa Healthcare)
Bond L, Toumbourou JW, Thomas L, Catalano 
RF & Patton G 2004 “Individual, family, school, and 
community risk and protective factors for depressive 
symptoms in adolescents: a comparison of risk profiles 
for substance use and depressive symptoms”, Prevention 
Science, 6:2, 73–88
This study examines the relationship between 
adolescent depressive symptoms and risk and 
protective factors identified for substance use. A 
questionnaire, developed to measure these factors 
in a young person’s community, family, school, peer 
group, and individual characteristics for substance 
use, was used to assess associations with self-
reported depressive symptoms.
DrugInfo Clearinghouse no. vf BOND 05
Gil AG, Wagner EF & Tubman JG 2004 “Associations 
between early-adolescent substance use and subsequent 
young-adult substance use disorders and psychiatric 
disorders among a multiethnic male sample in South 
Florida”, American Journal of Public Health, 94:9, 
1603–9
There were strong associations between early-
adolescent substance use and young-adult substance 
use disorders and psychiatric disorders. The 
magnitudes of these associations varied by racial/
ethnic group and were strongest among African 
Americans and foreign-born Hispanics, who reported 
the lowest early-adolescent substance use. (APHA)
DrugInfo Clearinghouse no. vf GIL 04
Bolognini M 2003 “Adolescent’s suicide attempts: 
populations at risk, vulnerability and substance use”, 
Substance Use and Misuse, 38:11–13, 1651–69
This article investigates strategies that might be 
used, at a social or political level, to prevent or 
minimise drug misuse and suicide attempts among 
adolescents.
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Patton G, Bond L, Butler H & Glover S 2003 
“Changing schools, changing health? Design and 
implementation of the Gatehouse Project”, Journal of 
Adolescent Health, 33:4, 231–9 
The Gatehouse Project addresses the social context 
of high school with an aim of changing students’ 
sense of school connection and in turn, health risk 
behaviour and wellbeing. Features of the project were 
its conceptual framework, implementation process, 
and evaluation design. The Gatehouse Project 
drew on both health and education research to 
develop and coordinate a broad-based school health 
promotion intervention. It represents a promising 
new direction for school-based preventive work.
DrugInfo Clearinghouse no. vf PATTON 03
Clark DB, Vanyukov M & Cornelius J 2002 
“Childhood antisocial behaviour and adolescent alcohol 
use disorder”, Alcohol Research & Health, 26:2, 109–15
This article investigates the link between childhood 
antisocial behaviours, such as conduct disorder, and 
the development of adolescent alcohol use disorders, 
later on. Discusses prevention programs and clinical 
interventions to reduce the risk of adolescent alcohol 
use disorders developing.
DrugInfo Clearinghouse no. vf CLARK 02
Deas D & Thomas S 2002 “Comorbid psychiatric 
factors contributing to adolescent alcohol and other 
drug use”, Alcohol Research & Health, 26:2, 116–21
This article looks at the factors which place 
adolescents at risk of alcohol and other drug use, 
such as psychological and psychiatric risk factors, 
peer influence, environmental and family factors.
DrugInfo Clearinghouse no. vf DEAS 02
Freres DR, Gillham J E, Reivich KJ, & Shatté AJ 
2002 “Preventing depressive symptoms in middle school 
students: The Penn Resiliency Program”, International 
Journal of Emergency Mental Health, 4:1, 31–40
This article describes the content of the  
program and evidence for the program’s  
efficacy in preventing depressive symptoms in  
early adolescence. (IJEMH)
DrugInfo Clearinghouse no. vf FRERES 02
Beitchman JH, Adlaf EM, Douglas L, Atkinson L, 
Young A, Johnson CJ, Escobar M & Wilson B 2001 
“Comorbidity of psychiatric and substance use disorders 
in late adolescence: a cluster analytic approach”, 
American Journal of Drug and Alcohol Abuse, 27:3, 
421–40 
Cluster analysis was used to identify subgroups 
of young people with past-year substance and/
or psychiatric disorders A large proportion of the 
depressed drug abusers and the antisocial cluster 
group had speech/language impairment that 
was identified at age 5 years. Clarification of the 
developmental progress of the young people in these 
cluster groups can inform our approach to early 
intervention and treatment. (AJDAA)
Chassin L, Pitts SC, DeLucia C & Todd M 1999 
“A longitudinal study of children of alcoholics. Predicting 
young adult substance use disorders, anxiety, and 
depression”, Journal of Abnormal Psychology, 108:1, 
106–19 
This study tested the specificity of parent alcoholism 
effects on young adult alcohol and drug abuse—
dependence, anxiety, and depression, and tested 
whether adolescent symptomatology and substance 
use mediated parent alcoholism effects. (APA)
vf CHASSIN 99
Zeitlin H 1999 “Psychiatric comorbidity with substance 
misuse in children and teenagers”, Drug and Alcohol 
Dependence 55:3, 225–34 
Substance misuse in children and young people is 
frequently associated with emotional and behavioural 
disorder not attributable directly to the effects of 
the substance. Such comorbid disorders include 
depression, suicidal behaviour, conduct disorder, 
attention deficit hyperactivity disorder, eating 
disorders, and psychosis. Some indication of causal 
links in specific samples has been found but there is 
not overall agreement. (DAD)
Books/reports
Cook S, Miller K & Parr V 2007 Alerting the 
community to the link between illicit drugs and mental 
illness Canberra: Australian Government Department of 
Health and Ageing
This report explores awareness, attitudes and 
perceptions of the link between illicit drugs and 
mental illness among young people their parents and 
the broader community.
http://www.health.gov.au/internet/wcms/publishing.
nsf/Content/phd-pub-illicit-mental-health
Ungar M 2006 Strengths-based counseling with at-risk 
youth, Thousand Oaks, CA: Sage
This book, aimed at those who work with young 
people at high risk of problem behaviour, sets out  
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a new way of understanding their motivations,  
and recognising their strengths, to help them 
overcome problems with violence, bullying,  
drug use and promiscuity.
DrugInfo Clearinghouse no. adf TZ22 UNG
Szirom T 2005 Barriers to service provision for young 
people with presenting substance misuse and mental 
health problems, Canberra, ACT: Australian Government 
Department of Family and Community Services
This is the final report of an investigation into barriers 
to service for young people with dual diagnoses. 
Thirty-two separate recommendations were made, 
including the recommendation that young people 
and indigenous young people be highlighted as  
“at-risk” communities.
http://www.facs.gov.au/internet/facsinternet.nsf/
aboutfacs/programs/youth-barriers_to_health_
provision.htm
New South Wales Association for Adolescent 
Health 2003 Caught in the gap. Dual diagnosis and 
young people. A report on the issue, Sydney: NAAH
This key discussion paper on dual diagnosis follows 
on from a large community forum on dual diagnosis 
and young people, held in August 2002. Includes 
recommendations, definitions and a literature review.
http://www.naah.org.au/DDReport.pdf
DrugInfo Clearinghouse no. vf NAAH 03
Teesson M & Proudfoot H 2003 Comorbid mental 
disorders and substance use disorders. Epidemiology 
prevention and treatment, Sydney: National Drug and 
Alcohol Research Centre
The issue of comorbidity between mental disorders 
and substance use disorders is demanding attention 
from researchers, clinicians and policy makers. 
Despite this demand there is little guidance to date 
regarding best practices in this field. Here experienced 
practitioners discuss recent research and interventions.
http://www.health.gov.au/internet/wcms/publishing.
nsf/Content/health-pubhlth-publicat-document-
mono_comorbid-cnt.htm
DrugInfo Clearinghouse no. GC42 TEE
Fiske G 2000 Communities That Care. A prevention 
approach to build the resilience of young people 
in our communities. A report of the study visit of 
Communities That Care Initiatives in the US an UK 
for the Department of Human Services, Melbourne: 
Department of Human Services
The report gives the reader an overview of the context 
for the Communities That Care development, current 
overseas policy and program implementations of 
Communities That Care by government and other 
agencies, and the evaluation of the Communities That 
Care effectiveness by funding and other bodies. (DHS)
http://www.office-for-children.vic.gov.au/policy-
planning-funding/library/publications/communities_
that_care
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Audiovisual
Rural Health Education Foundation 2006 The Can 
Do Initiative. Managing mental health and substance 
abuse in general practice DVD, Deakin, ACT: Rural Health 
Education Foundation
This 87 minute DVD, presented in a panel discussion 
style, aims to equip general practitioners to identify, 
treat and support people with mental health and 
substance abuse issues. Chaired by Ms Kate Carnell AO, 
panel members include Dr Maggie Brady, Ms Annie 
Madden, Prof. David Kavanagh and Assoc. Prof. Moira 
Sim. The discussion includes information specifically 
related to Indigenous communities. 
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All material listed is available from the Australian Drug Foundation library.
Membership to the library is open to professionals in Victoria who work in the areas of health, welfare, and education.
Members are able to borrow from the collection as well as access other services provided by the library. Membership is free  
to these groups.
For more information about membership or how to access material: 
Tel.  (03) 9278 8121 (Monday to Friday, 9am to 5pm) 
Fax. (03) 9328 3008 
Email library@adf.org.au
Or visit our website at www.druginfo.adf.org.au/library
www.druginfo.adf.org.au
DrugInfo Clearinghouse
409 King Street West Melbourne VIC 3003
Email. druginfo@adf.org.au
